EIDD-2749 (4-FlU), a ribonucleoside analog, is an orally available RdRp inhibitor with spectroscopic antiviral activity that interrupts the replication of respiratory syncytial virus and SARS-CoV-2.EIDD-2749 attenuates lethal infections of pandemic human and highly pathogenic avian influenza viruses.
Molecular Weight:
262.19
Purity:
97.39%
CAS Number:
[1613589-24-4]
Formula:
C9H11FN2O6
Target:
HCV Protease|||Antiviral|||SARS-CoV|||RSV
T73253
* VAT and and shipping costs not included. Errors and price changes excepted